Cargando…
Kushenin combined with entecavir for chronic hepatitis B: A protocol for a systematic review and meta-analysis
BACKGROUND: A recent study has reported that there are >240 million patients infected with chronic hepatitis B (CHB) worldwide. Once patients with CHB start antiviral treatment, they need to take antiviral drugs for a long period, which may lead to a series of side effects, and the resistance to...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004585/ https://www.ncbi.nlm.nih.gov/pubmed/32000393 http://dx.doi.org/10.1097/MD.0000000000018898 |